FDA issued a Warning Letter to Opto-Pharm Pte Ltd. on 3/16/2017 as a result of this inspection.
483 Opto-Pharm Pte Mar 2016
483 Opto-Pharm Pte Mar 2016Linda Murphy FDA$119.00 - Available Now
FDA investigators audited the Opto-Pharm Pte - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 22 Mar 2016.
Add To Cart
- Category: Human Drugs
- Inspection end: 22 Mar 2016
- Location: Singapore, Singapore
- FEI: 3005320466